Literature DB >> 12101413

Brca1 regulates in vitro differentiation of mammary epithelial cells.

Marion Kubista1, Margit Rosner, Ernst Kubista, Gerhard Bernaschek, Markus Hengstschläger.   

Abstract

Murine Brca1 is widely expressed during development in different tissues. Why alterations of BRCA1 lead specifically to breast and ovarian cancer is currently not clarified. Here we show that Brca1 protein expression is upregulated during mammary epithelial differentiation of HC11 cells, during differentiation of C2C12 myoblasts into myotubes and during neuronal differentiation of N1E-115 cells. Ectopic overexpression of BRCA1 and downregulation of endogenous Brca1 expression specifically affect the regulation of mammary epithelial cell differentiation. Accelerated mammary epithelial cell differentiation upon high ectopic BRCA1 expression is not a consequence of the anti-proliferative capacity of this tumor suppressor and independent of functional p53. Overexpression of the BRCA1 variant lacking the large central exon 11 has no effects on mammary epithelial cell differentiation. These data provide new insights into the cellular role of Brca1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101413     DOI: 10.1038/sj.onc.1205580

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

Review 1.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

2.  BRCA1 is a novel regulator of metabolic function in skeletal muscle.

Authors:  Kathryn C Jackson; Eva-Karin Gidlund; Jessica Norrbom; Ana P Valencia; David M Thomson; Rosemary A Schuh; P Darrell Neufer; Espen E Spangenburg
Journal:  J Lipid Res       Date:  2014-02-24       Impact factor: 5.922

Review 3.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

4.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.

Authors:  Penney M Gilbert; Janna K Mouw; Meredith A Unger; Johnathon N Lakins; Mawuse K Gbegnon; Virginia B Clemmer; Miriam Benezra; Jonathan D Licht; Nancy J Boudreau; Kelvin K C Tsai; Alana L Welm; Michael D Feldman; Barbara L Weber; Valerie M Weaver
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

5.  Transcriptional regulation of the base excision repair pathway by BRCA1.

Authors:  Tapas Saha; Jeong Keun Rih; Rabindra Roy; Rahul Ballal; Eliot M Rosen
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

6.  The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Authors:  Yongxian Ma; Pragati Katiyar; Laundette P Jones; Saijun Fan; Yiyu Zhang; Priscilla A Furth; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2005-08-18

Review 7.  SLUG: Critical regulator of epithelial cell identity in breast development and cancer.

Authors:  Sarah Phillips; Charlotte Kuperwasser
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 8.  Hypoxic tumor microenvironment and cancer cell differentiation.

Authors:  Yuri Kim; Qun Lin; Peter M Glazer; Zhong Yun
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

9.  BRCA1 regulates human mammary stem/progenitor cell fate.

Authors:  Suling Liu; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Hailey Foco; Celina G Kleer; Sofia D Merajver; Gabriela Dontu; Max S Wicha
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

10.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.